Historical Background
Nucleoside triphosphate diphosphohydrolases (NTPDases), originally ATP diphosphohydrolases (ATPDases) with the common name apyrase, are by definition enzymes which split the γ- and β-phosphate residues of triphospho- and diphosphonucleosides such as ATP and ADP, respectively. Before the cloning of the gene, the common name apyrase was generally used for enzymes that exhibit this activity in plants and invertebrates while the terms ecto-ATPase and ATP diphosphohydrolase (ATPDase) were rather used in vertebrates. Shortly after cloning the first gene encoding such an enzyme, the nomenclature was unified in mammals to NTPDase, which better reflects the ability of these enzymes to convert not only ATP and ADP, but also other triphospho- and diphosphonucleosides.
A first apyrase was discovered in potato tubers in...
References
Beaudoin AR, Sévigny J, Picher M. ATP-diphosphohydrolases, apyrases, and nucleotide phosphohydrolases: biochemical properties and functions. In: Lee AG, editor. ATPases. Greenwich: JAI Press; 1996. p. 369–401.
Bigonnesse F, Lévesque SA, Kukulski F, Lecka J, Robson SC, Fernandes MJG, et al. Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry. 2004;43(18):5511–9.
Deaglio S, Robson SC. Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol. 2011;61:301–32.
Enjyoji K, Sévigny J, Lin Y, Frenette PS, Christie PD, Schulte Am Esch IIJ, et al. Targeted disruption of CD39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med. 1999;5(9):1010–7.
Friedman DJ, Kunzli BM, Yi AR, Sévigny J, Berberat PO, Enjyoji K, et al. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Nat Acad Sci USA. 2009;106(39):16788–93.
Grinthal A, Guidotti G. CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why? Purinergic Signal. 2006;2(2):391–8.
Ivanenkov VV, Meller J, Kirley TL. Characterization of disulfide bonds in human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3): implications for NTPDase structural modeling. Biochemistry. 2005;44(25):8998–9012.
Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR, et al. Identification and characterization of CD39 vascular ATP diphosphohydrolase. J Biol Chem. 1996;271(51):33116–22.
Kegel B, Braun N, Heine P, Maliszewski CR, Zimmermann H. An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacology. 1997;36(9):1189–200.
Kirley TL. Complementery DNA cloning and sequencing of the chicken muscle ecto-ATPase – homology with the lymphoid cell activation antigen CD39. J Biol Chem. 1997;272(2):1076–81.
Knowles AF. The GDA1_CD39 superfamily: NTPDases with diverse functions. Purinergic Signal. 2011;7(1):21–45.
Kukulski F, Lévesque SA, Lavoie EG, Lecka J, Bigonnesse F, Knowles AF, et al. Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signal. 2005;1(2):193–204.
Kukulski F, Lévesque SA, Sévigny J. Impact of ectoenzymes on P2 and P1 receptor signaling. Adv Pharmacol. 2011;61:263–99.
Massé K, Bhamra S, Eason R, Dale N, Jones EA. Purine-mediated signalling triggers eye development. Nature. 2007;449(7165):1058–62.
Mizumoto N, Kumamoto T, Robson SC, Sévigny J, Matsue H, Enjyoji K, et al. CD39 is the dominant langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med. 2002;8(4):358–65.
Plesner L. Ecto-ATPases: identities and functions. Int Rev Cytol. 1995;158:141–214.
Robson SC, Sévigny J, Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal. 2006;2(2):409–30.
Sévigny J, Sundberg C, Braun N, Guckelberger O, Csizmadia E, Qawi I, et al. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood. 2002;99(8):2801–9.
Smith TM, Kirley TL. Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ecto-apyrases. Biochim Biophys Acta Protein Struct Mol Enzymol. 1998;1386(1):65–78.
Wang T-F, Guidotti G. CD39 is an ecto-(Ca2+, Mg2+)-apyrase. J Biol Chem. 1996;271:9898–901.
Yegutkin GG. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta. 2008;1783(5):673–94.
Zebisch M, Strater N. Structural insight into signal conversion and inactivation by NTPDase2 in purinergic signaling. Proc Natl Acad Sci USA. 2008;105(19):6882–7.
Zimmermann H, Beaudoin AR, Bollen M, W. GJ, Guidotti G, Kirley TL, et al., editors. Proposed nomenclature for two novel nucleotide hydrolyzing enzyme families expressed on the cell surface. Proceedings of the Second International Workshop on Ecto-ATPases and Related Ectonucleotidases; 1999/2000; Diepenbeek, Belgium\Maastricht: Shaker; 2000
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this entry
Cite this entry
Sévigny, J. (2012). E-NTPDase Family. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0461-4_197
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0461-4_197
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0460-7
Online ISBN: 978-1-4419-0461-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences